Protein phosphorylation at tyrosine residues is a key regulatory event that modulates insulin signal transduction. We studied the PTPN1 gene with regard to susceptibility to Korean type 2 diabetes mellitus (T2DM) and its related quantitative traits.
Introduction
Protein phosphorylation at tyrosine residues modulates intracellular signaling pathways, and this modulation is an essential determinant of insulin signal transduction (Goldstein et al., 1998; Evans and Jallal, 1999) . Protein tyrosine phosphatase 1B protein (PTP1B), encoded by the PTPN1 gene, regulates the tyrosine phosphorylation of insulin receptor (Seely et al., 1996) and insulin receptor substrate 1 (Goldstein et al., 2000) , which leads to downregulation of insulin signaling. PTPN1 deficiency in mice results in increased insulin sensitivity (Elchebly et al., 1999) and enables normalization of blood glucose levels (Klaman et al., 2000) . Moreover, it has been shown that inactivation with antisense oligonucleotides regulates the expression of genes that are involved in lipogenesis, such as SREBF1, suggesting that PTP1B may play a role in the enlargement of adipocyte energy storage (Rondinone et al., 2002) .
The human PTPN1 gene maps to chromosome 20q13.13, a syntenic region of the distal arm of mouse chromosome 2 that harbors quantitative trait loci for body fat and body weight (Lembertas et al., 1997) . The PTPB1 gene consists of 10 exons, spanning 74 kb, and the first intron is longer than 50 kb. In humans, several linkage signals with type 2 diabetes mellitus (T2DM) (Bowden et al., 1997) , BMI (Hunt et al., 2001) , fat mass, and energetic intake (Collaku et al., 2004; Dong et al., 2003; Lembertas et al., 1997) were reported at this locus in different populations, further supporting the candidacy of PTPN1 involvement in T2DM and obesity. In
Poland, a family-based linkage study of T2DM showed the highest logarithm of the odds score (Ji et al., 1997; Klupa et al., 2000) . This locus also showed evidence of linkage with early onset T2DM (onset=45 years) in a subset of 55 French families (Zouali et al., 1997) .
Since the discovery of the PTPN1 gene (Forsell et al., 2000) , multiple studies have attempted to examine its role in susceptibility to T2DM. A missense variant in the coding region of PTPN1 was found to be associated with T2DM and glucose tolerance in the Danish population (Echwald et al., 2002) , and an insertion/deletion polymorphism in the 3'-untranslated region was associated with insulin resistance (Di Paola et al., 2002) . In an extensive analysis of the PTPN1 gene locus, Bento et al. (2004) observed associations between multiple SNPs and T2DM in two independent CaucasianAmerican case-control samples. The evidence for association was most consistent for SNPs in the region that spanned the 3'-end of intron 1 to the last, intron 8. All of the associated SNPs lay in a single haplotype block, and one common haplotype (frequency=36%) was found to be strongly associated with T2DM. The same group evaluated and confirmed previous findings of SNPs and haplotypes of PTPN1 for association with quantitative glycemic traits in Hispanic-American subjects from the Insulin Resistance Atherosclerosis Study Family Study (IRASFS) . However, a recent meta-analysis that included 7883 individuals from three large European case-control samples (from the US, Poland, and Scandinavia) did not replicate this association for any single SNP or haplotype (Florez et al., 2005) . A conclusion of the association between PTPN1
and T2DM in Asian and African populations is needed. Despite the inconsistency of the association with T2DM, the evidence that PTPN1 might be a significant contributor to genetic susceptibility to T2DM seems to be strong. Because no study of PTPN1 in association with T2DM in the Asian population has been presented, we provide the first report of the susceptibility of the PTPN1 gene in Korean T2DM and its related quantitative traits.
Methods

Subjects
The 24 DNA samples from Korean subjects that were used for the initial sequencing were randomly selected from unrelated local residents with no history of familial diseases. With 24 samples (48 chromosomes), it might be expected that more than 90% of SNPs have a frequency that is greater than 0.05 (Eberle and Kruglyak, 2000) . We studied 483 unrelated patients with type 2 diabetes (age: 64±2.8 years, onset age: 56±8.1 years; 206 men, 277 women) and 1138 nondiabetic control subjects (age: 64±2.9; 516 men, 622 women). All subjects who enrolled in this study originated from the Ansung-Ansan prospective community cohort.
In this study, diabetic subjects were recruited according to American Diabetes Association criteria from 10,038 individuals in the Ansung-Ansan prospective community cohort. Nondiabetic subjects who had no history of diabetes, no first-degree relatives with diabetes, fasting plasma glucose levels less than 6.1 mmol/L, and hemoglobin A1c (HbA1c) levels less than 5.8% were recruited from the cohort. To be eligible, normal control subjects also had to be free of medications for diabetes, hypertension, and dyslipidemia. The study was approved by the institutional review board of the Korean National Institute of Health. Written informed consent was obtained from all subjects.
Measurement of clinical characteristics
Both T2DM and normal control subjects were aged 60 years and older. The clinical characteristics of the subjects are summarized in Table 1 . All study subjects were examined in the morning after an overnight fast and 60 min and 120 min after an oral glucose tolerance test (OGTT). The parameters that were measured were height, weight, body mass index [BMI: weight (kg)/ square of height (m 2 )], waist and hip circumference, waist-to-hip ratio (WHR: waist/hip), and blood pressure. Blood samples were drawn for biochemical measurements: fasting plasma glucose (GLU0), OGTT 60 min and 120 min plasma glucose (GLU60 and GLU120, respectively), fasting plasma insulin (INS0), OGTT 60 min and 120 min plasma insulin (INS60 and INS120, respectively), HbA1c, total cholesterol (TCHL), triglycerides (TG), and high-density lipoprotein cholesterol (HDL). Using the measurements, low-density lipoprotein cholesterol [LDL: TCHL-TG-(HDL/5)], area under glucose curve (AUCGLU), area under insulin curve (AUCINS), homeostasis model assessment of insulin resistance [HOMA-IR: GLU0*INS0/(22.5*14.182)], quantitative insulin sensitivity check index [QUICKI: 1/(log(GLU0)＋log(INS0)], and insulin sensitivity index (ISI) were calculated. The QUICKI was derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose levels. This index correlates well with glucose clamp studies (r=0.78) and is useful for measuring insulin sensitivity (IS), which is the inverse of insulin resistance (IR) (Katz et al., 2000) .
Sequencing analysis of the human PTPN1 gene
We sequenced all exons, including exon-intron boundaries and the promoter region (approximately 1.5 kb), to discover single nucleotide polymorphisms (SNPs) in 24 DNA samples from Koreans using the ABI PRISM 3730 DNA analyzer (Applied Biosystems, Foster City, CA, 
Genotyping
Among the identified polymorphisms, seven SNPs (g.36171G＞A, g.58166G＞A, 58208A＞G, g.64840C＞T, g.69560C＞G, g.69866G＞A, and g.69934T＞G) were selected based on frequency (＞0.05), linkage disequilibrium (LD) status, and haplotype tagging status. In addition, one indel (g.1484G_ins) was selected based on previous reports Burdon et al., 2006) . SNPs were genotyped using amplifying primers and probes designed for TaqMan (Livak, 1999) . Primer Express (Applied Biosystems) was used to design both the PCR primers and the MGB TaqMan probes. One allelic probe was labeled with the FAM dye, and the other was labeled with the fluorescent VIC dye. PCRs were run in TaqMan Universal Master mix without UNG (Applied Biosystems) and with PCR primer concentrations of 900 nM and TaqMan MGB probe at a concentration of 200 nM. Reactions were performed in 384-well format in a total reaction volume of 5μl using 20 ng of genomic DNA. The plates were then placed in a thermal cycler (PE 9700, Applied Biosystems) and heated at 50 Fluorescence data files from each plate were analyzed using automated software (SDS ver. 2.1, Applied Biosystems).
Statistics
Differences in anthropometric and physiologic variables between nondiabetic and diabetic subjects were com- , 2005) . Haplotypes were inferred using Haploview. Differences in genotype frequencies between T2DM patients and controls were compared using the chi square test, and the mode of inheritance was analyzed by a logistic regression procedure. Genotypes were given codes of 0, 1 and 2; 0, 1 and 1; 0, 0 and 1 in the additive, dominant, and recessive models, respectively. The associations between SNPs or haplotypes and T2DM-related subphenotypes were determined by linear regression analysis while controlling for age, sex, and BMI among normal control subjects. The SAS statistical software package (SAS Institute Inc. Cary, NC, USA) was used to perform general statistical analyses. Statistical significance was determined at a two-tailed value of p＜0.05.
Korean SNP database
Information on most of the SNPs that are described in this study is available in the Korean SNP database (http://www.ngri.re.kr/SNP/), which was constructed at the Center for Genome Sciences (Korean National Institute of Health).
Results
Most of the variables that are shown in Table 1 were significantly higher in T2DM patients than normal controls, but HDL cholesterol and INS60 [insulin level at 1 hour after oral glucose tolerance test (OGTT)] were lower in T2DM patients than in normal controls, and no significant differences were observed in diastolic blood pressure or AUCINS (area under the curve in insulin level during OGTT) between groups. Through direct sequencing of all exons and their boundaries in the PTPN1 gene, including up to -1500 bp of the 5'-flanking region, 19 SNPs were identified ( Table 2 ). The genomic positions of the SNPs are illustrated in Fig. 1A . The SNPs that were selected for further study are in bold and with an asterisk (*); they had more than a 5% allele frequency and a tagging of the linkage disequilibrium (LD) block (data not shown). None of the SNPs deviated from HWE (Hardy- Underline indicates significant result with p-value＜0.05. Weinberg Equilibrium). An insertion/deletion variant (g.1484G_ins) was not polymorphic in our subjects. The selected seven SNPs belonged to an LD block with |D'| ＞0.98 (Fig. 1B) . Five haplotypes with greater than a 5% frequency were predicted using the case-control samples (Fig. 1C) . The results of the logistic regression analysis are described in Table 3 . rs941798 had a protective effect against diabetes, with an odds ratio of 0.726 (C.I. 0.541∼0.975) and p-value=0.034. Underline indicates significant result with p-value＜0.05.
The insulin resistance index had no significant association, except for log-transformed QUICKI and ISI (Table 4) . The SNPs rs941798, rs2904270, rs9417114, rs718050, and rs3787348 showed significant association with QUICKI, but the differences were not distinguishable. The SNPs rs941798 and rs3787348 revealed a significant association with ISI, in which the individuals with minor alleles showed a decreased ISI.
Other quantitative traits that were related to T2DM were analyzed. Although there was no significant result between PTPN1 and the obesity indices (BMI and WHR) (data not shown), significant associations with blood pressure were observed for six SNPs (rs941798, rs2904270, rs754118, rs6020612, rs718050 , and rs3787348) ( Table 5 ). Individuals that had risk alleles of the six SNPs had significantly increased systolic and diastolic blood pressures. In addition, SNPs rs941798, rs2904270, rs754118, rs718050, and rs3787348 were associated with decreased HDL cholesterol levels in the codominant or dominant model (Table 6 ). SNP rs6020612 re- Underline indicates significant result with p-value＜0.05.
vealed increased triglycerides in the recessive model, but there were only 2 subjects that were homozygous for the minor allele.
Discussion
In this study, we investigated the effect of seven PTPN1
SNPs on susceptibility to T2DM and its related quantitative traits in a Korean Ansung-Ansan prospective community cohort. Our T2DM association results are similar to those that were found for the Caucasian-American population and Hispanic-American population but differ from a European study (Florez et al., 2005) , which did not find any significant associations even though they obtained the same haplotype block. A total of five SNPs consisting of haplotype 2 (Fig.  1C) showed a significant association with QUICKI. Two (rs941798 and rs3787348) of the five SNPs also were associated with ISI. The results imply that the association between PTPN1 and T2DM may be caused by insulin resistance. Although the association with QUICKI was significant, the differences between genotypes were not clear. However, the ISI was decreased in individuals who had at least one minor allele. This result is well supported by a previous report .
The association between the PTPN1 gene and blood pressure was greatly in concordance with previous two reports (Cheyssac et al., 2006; Spencer-Jones et al., 2005) . Both reports suggested that PTPN1 gene variants increase blood pressure. Moreover, our results showed a more significant increase in systolic blood pressure in homozygotes of the SNP rs718050 minor allele.
Although PTPN1 is an important regulator of the insulin signaling pathway, these results imply that SNP rs718050 may be a useful marker to predict hypertension. We also identified the increased tendency of TG in homozygotes of rs6020612; the minor allele homozygotes were observed in only two individuals. Although this association was reported in other reports (Cheyssac et al., 2006; Spencer-Jones et al., 2005) , the associated SNP had a higher frequency of minor allele homozygotes. Therefore, the association between PTPN1 and TG should be confirmed using other SNPs that have been previously reported.
PTP1B also inhibits leptin signaling through the dephosphorylation of JAK2 and STAT3 (Zabolotny et al., 2002; Cheng et al., 2002) . Moreover, it was shown that inactivation with antisense oligonucleotides regulates the Underline indicates significant result with p-value＜0.05.
expression of genes that are involved in lipogenesis, such as SREBF1, suggesting that PTP1B may play a role in the enlargement of adipocyte energy storage (Rondinone et al., 2002) . Two SNPs (rs941798 and rs3787348) effected decreased HDL cholesterol levels in minor allele homozygotes. This result also has been replicated in another report (Cheyssac et al., 2006) , but the previous report showed a marginal association, while our results revealed lower p-values (rs941794 p=0.002, and rs3787348 p=0.003). Both SNPs showed a significant association with blood pressure, implying that the increased blood pressure might result in low HDL cholesterol levels and be related to lipid metabolism, which is another molecular pathway of PTPN1 function (Santaniemi et al., 2004) . This is the first report that shows the association between PTPN1 and T2DM in the Korean as well as Asian population. We hope this study will increase our knowledge about T2DM pathophysiology.
